ATOSSA THERAPEUTICS INC has a total of 33 patent applications. It increased the IP activity by 2200.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are VIRACTA THERAPEUTICS INC, MARKOV ILYA ALEKSANDROVICH and SICHUAN JIUZHANG BIO-TECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 5 | |
#3 | United States | 5 | |
#4 | Canada | 4 | |
#5 | Israel | 4 | |
#6 | Republic of Korea | 4 | |
#7 | Singapore | 4 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Organic chemistry methods | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Microorganisms | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Quay Steven C | 25 |
#2 | Kisak Edward T | 9 |
#3 | Newsam John M | 9 |
#4 | Kushwaha Avadhesh S | 9 |
#5 | Wang Lunghu | 6 |
#6 | Sun Yaolin | 6 |
#7 | Huang Chuander | 6 |
#8 | Wu Changjung | 6 |
#9 | Quay Steven | 4 |
#10 | Kushwaha Avadhesh | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021003433A1 | Sustained release compositions of endoxifen | |
US2021060052A1 | In situ methods of inducing of immune response | |
KR20200103764A | How to treat breast disorders in the tube | |
EP3681478A1 | Topical compositions and methods for treatment | |
US2020207704A1 | Methods for making and using endoxifen |